Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers

Current Medical Research and Opinion

Volumn 25, Issue 10, 2009, Pages 2423-2428

  Lissy, Michael ^a   Stiff, Dwight D ^a   Kowalski, Mark M ^b,c   Moore, Keith A ^d  

^a AAIPharma Inc   (Germany)

^b AAIPharma Inc   (United States)

^c Viventia Biotech Inc   (Canada)

^d Xanodyne Pharmaceuticals Inc   (United States)

Author keywords

Bioequivalence; Diclofenac potassium; Dispersion technology; Pharmacokinetics; Prosorb

Indexed keywords

DICLOFENAC POTASSIUM;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL PATIENT; HUMAN; LINGUAL PARESTHESIA; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; ORAL PARESTHESIA; SINGLE DRUG DOSE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DICLOFENAC; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; REFERENCE VALUES;

EID: 70349325852     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903158513     Document Type: Article

References (28)

1. Top 200 generic drugs by units in 2006. Drug Topics. Woodland Hills, CA: Modern Medicine.com, a service of Advanstar Communications, Inc., 2008. Available at www.drugtopics.com/drugtopics/data/articlestandard//drugtopics/ 092007/407652/article.pdf [Last accessed 12 February 2008]
2. Label and approval history for Voltaren. Drugs@FDA. Washington, DC: FDA/Center for Drug Evaluation and Research, 2008. Available at www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search. Overview&DrugName=VOLTAREN [Last accessed 13 February 2008]
3. Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005;365:475-481 (Pubitemid 40215729)
4. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;330:1366 (Pubitemid 40839565)
5. Mitchell JA, Warner TD. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 1999;128:1121-1132
6. Moore N. Diclofenac potassium 12.5 mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety. Clin Drug Investig 2007;27:163-195 (Pubitemid 46440303)
7. Bakshi R, Frenkel G, Dietlein G, et al. A placebo-controlled comparative evaluation of diclofenac dispersible versus ibuprofen in postoperative pain after third molar surgery. J Clin Pharmacol 1994;34:225-230 (Pubitemid 24102090)
8. Breivik EK, Barkvoll P, Skovlund E. Combining diclofenac with acetaminophen or acetaminophen-codeine after oral surgery: a randomized, double-blind single-dose study. Clin Pharmacol Ther 1999;66:625-635 (Pubitemid 30014091)
9. Hersh EV, Levin LM, Adamson D, et al. Dose-ranging analgesic study of Prosorb diclofenac potassium in postsurgical dental pain. Clin Ther 2004;26:1215-1227 (Pubitemid 39420316)
10. Matthews RW, Scully CM, Levers BG. The efficacy of diclofenac sodium (Voltarol) with and without paracetamol in the control of post-surgical dental pain. Br Dent J 1984;157:357-359
11. Bamber MJ, Tweedie IE, Breeze C, et al. Premedication with controlled release diclofenac sodium reduces post-operative pain after minor gynaecological surgery. Eur J Anaesthesiol 1997;14:421-427 (Pubitemid 27427381)
12. McEvoy A, Livingstone JI, Cahill CJ. Comparison of diclofenac sodium and morphine sulphate for postoperative analgesia after day case inguinal hernia surgery. Ann R Coll Surg Engl 1996;78:363-366 (Pubitemid 26241660)
13. Hinz B, Chevts J, Renner B, et al. Bioavailability of diclofenac potassium at low doses. Br J Clin Pharmacol 2005;59:80-84 (Pubitemid 40040099)
14. Lötsch J, Kettenmann B, Renner B, et al. Population pharmacokinetics of fast release -oral diclofenac in healthy volunteers: relation to pharmacodynamics in an experimental pain model. Pharm Res 2000;17:77-84 (Pubitemid 30121103)
15. Macia MA, Frias J, Carcas AJ, et al. Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks. Int J Clin Pharmacol Ther 1995;33:333-339
16. Reiner V, Reiner A, Reiner G, et al. Increased absorption rate of diclofenac from fast acting formulations containing its potassium salt. Arzneimittelforschung 2001;51:885-890 (Pubitemid 33096108)
17. Riad LE, Sawchuk RJ, McAlary MM, et al. Effect of food on the multiple-peak behavior after a single oral dose of diclofenac sodium slow-release tablet in humans. Am J Ther 1995;2:237-242
18. Terhaag B, Hoffmann A, Barkworth M, et al. Bioavailability of a new effervescent tablet of diclofenac. Int J Clin Pharmacol Ther 2000;38:546-551 (Pubitemid 30819441)
19. Ceppi Monti N, Gazzaniga A, Gianesello V, et al. Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen. Arzneimittelforschung 1992;42:556-559
20. Laska EM, Sunshine A, Marrero I, et al. The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther 1986;40:1-7 (Pubitemid 16057974)
21. Seymour RA, Hawkesford JE, Weldon M, et al. An evaluation of different ibuprofen preparations in the control of postoperative pain after third molar surgery. Br J Clin Pharmacol 1991;31:83-87
22. Mojaverian P, Rocci Jr ML, Conner DP, et al. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time. Clin Pharmacol Ther 1987;41:11-17 (Pubitemid 17008124)
23. Sanchez J, Martinez L, Garcia-Barbal J, et al. The influence of gastric emptying on droxicam pharmacokinetics. J Clin Pharmacol 1989;29:739-745 (Pubitemid 19222377)
24. Welling PG. Interactions affecting drug absorption. Clin Pharmacokinet 1984;9:404-434
25. Vidon N, Pfeiffer A, Godbillon J, et al. Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: application to diclofenac. Br J Clin Pharmacol 1989;28:121-124 (Pubitemid 19195675)
26. Marzo A, Dal Bo L, Verga F, et al. Pharmacokinetics of diclofenac after oral administration of its potassium salt in sachet and tablet formulations. Arzneimittelforschung 2000;50:43-47
27. Silva LC, Simoes IG, Lerner FE, et al. Comparative bioavailability of two different diclofenac formulations in healthy volunteers. Arzneimittelforschung 1999;49:920-924
28. Cataflam (package insert). East Hanover, NJ: Novartis Pharmaceuticals Corporation, July 2005